Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

Published:2011-01 Issue:1 Volume:71 Page:89-93
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sun Jong-Mu,Ahn Jin Seok,Lee Soohyeon,Kim Jung A.,Lee Jeeyun,Park Yeon Hee,Park Hee Chul,Ahn Myung-Ju,Ahn Yong Chan,Park Keunchil

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001

2. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial;Rosen;Cancer,2004

3. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial;Kohno;J Clin Oncol,2005

4. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group;Rosen;J Clin Oncol,2003

5. Methodology for treatment evaluation in patients with cancer metastatic to bone;Cook;J Natl Cancer Inst,2001

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic pattern and prognosis in patients with lung adenosquamous carcinoma: A surveillance, epidemiology, and end results-based population study;Heliyon;2024-05

2. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter study;2024-02-15

3. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets;Therapeutic Advances in Medical Oncology;2024-01

4. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer;2023-09-15

5. Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients;Human Vaccines & Immunotherapeutics;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3